Aberdeen Group’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.9M Sell
688,760
-76,534
-10% -$1.66M 0.03% 494
2025
Q1
$18.6M Buy
765,294
+280,628
+58% +$6.81M 0.04% 414
2024
Q4
$10.1M Buy
+484,666
New +$10.1M 0.02% 508